Home > Publications database > Functional informed genome-wide interaction analysis of body mass index, diabetes and colorectal cancer risk. > print

001     154193
005     20240229123058.0
024 7 _ |a 10.1002/cam4.2971
|2 doi
024 7 _ |a pmid:32207560
|2 pmid
024 7 _ |a altmetric:78258625
|2 altmetric
037 _ _ |a DKFZ-2020-00649
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Xia, Zhiyu
|0 0000-0002-8340-8508
|b 0
245 _ _ |a Functional informed genome-wide interaction analysis of body mass index, diabetes and colorectal cancer risk.
260 _ _ |a Hoboken, NJ
|c 2020
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1596030619_24307
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2020 May;9(10):3563-3573
520 _ _ |a Body mass index (BMI) and diabetes are established risk factors for colorectal cancer (CRC), likely through perturbations in metabolic traits (e.g. insulin resistance and glucose homeostasis). Identification of interactions between variation in genes and these metabolic risk factors may identify novel biologic insights into CRC etiology.To improve statistical power and interpretation for gene-environment interaction (G × E) testing, we tested genetic variants that regulate expression of a gene together for interaction with BMI (kg/m2 ) and diabetes on CRC risk among 26 017 cases and 20 692 controls. Each variant was weighted based on PrediXcan analysis of gene expression data from colon tissue generated in the Genotype-Tissue Expression Project for all genes with heritability ≥1%. We used a mixed-effects model to jointly measure the G × E interaction in a gene by partitioning the interactions into the predicted gene expression levels (fixed effects), and residual G × E effects (random effects). G × BMI analyses were stratified by sex as BMI-CRC associations differ by sex. We used false discovery rates to account for multiple comparisons and reported all results with FDR <0.2.Among 4839 genes tested, genetically predicted expressions of FOXA1 (P = 3.15 × 10-5 ), PSMC5 (P = 4.51 × 10-4 ) and CD33 (P = 2.71 × 10-4 ) modified the association of BMI on CRC risk for men; KIAA0753 (P = 2.29 × 10-5 ) and SCN1B (P = 2.76 × 10-4 ) modified the association of BMI on CRC risk for women; and PTPN2 modified the association between diabetes and CRC risk in both sexes (P = 2.31 × 10-5 ).Aggregating G × E interactions and incorporating functional information, we discovered novel genes that may interact with BMI and diabetes on CRC risk.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Su, Yu-Ru
|b 1
700 1 _ |a Petersen, Paneen
|b 2
700 1 _ |a Qi, Lihong
|b 3
700 1 _ |a Kim, Andre E
|b 4
700 1 _ |a }, , USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
|0 0000-0003-1217-5249
|b 5
700 1 _ |a Figueiredo, Jane C
|b 6
700 1 _ |a }, , USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. | Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
|b 7
700 1 _ |a Lin, Yi
|b 8
700 1 _ |a Nan, Hongmei
|b 9
700 1 _ |a Sakoda, Lori C
|b 10
700 1 _ |a Albanes, Demetrius
|b 11
700 1 _ |a Berndt, Sonja I
|b 12
700 1 _ |a Bézieau, Stéphane
|b 13
700 1 _ |a Bien, Stephanie
|b 14
700 1 _ |a Buchanan, Daniel D
|0 0000-0003-2225-6675
|b 15
700 1 _ |a Casey, Graham
|b 16
700 1 _ |a Chan, Andrew T
|b 17
700 1 _ |a Conti, David V
|b 18
700 1 _ |a }, , USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
|b 19
700 1 _ |a Drew, David A
|b 20
700 1 _ |a Gallinger, Steven J
|b 21
700 1 _ |a Gauderman, W James
|b 22
700 1 _ |a }, , USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
|b 23
700 1 _ |a Giles, Graham G
|b 24
700 1 _ |a Gruber, Stephen B
|b 25
700 1 _ |a }, , USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
|b 26
700 1 _ |a Gunter, Marc J
|b 27
700 1 _ |a Hoffmeister, Michael
|0 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
|b 28
|u dkfz
700 1 _ |a Jenkins, Mark A
|b 29
700 1 _ |a Joshi, Amit D
|b 30
700 1 _ |a Le Marchand, Loic
|b 31
700 1 _ |a Lewinger, Juan P
|b 32
700 1 _ |a }, , USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
|b 33
700 1 _ |a Li, Li
|b 34
700 1 _ |a Lindor, Noralane M
|b 35
700 1 _ |a Moreno, Victor
|b 36
700 1 _ |a Murphy, Neil
|b 37
700 1 _ |a Nassir, Rami
|b 38
700 1 _ |a Newcomb, Polly A
|b 39
700 1 _ |a Ogino, Shuji
|b 40
700 1 _ |a Rennert, Gad
|b 41
700 1 _ |a Song, Mingyang
|b 42
700 1 _ |a Wang, Xiaoliang
|b 43
700 1 _ |a Wolk, Alicja
|b 44
700 1 _ |a Woods, Michael O
|b 45
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 46
|u dkfz
700 1 _ |a White, Emily
|b 47
700 1 _ |a Slattery, Martha L
|b 48
700 1 _ |a Giovannucci, Edward L
|b 49
700 1 _ |a Chang-Claude, Jenny
|0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
|b 50
|u dkfz
700 1 _ |a Pharoah, Paul D P
|b 51
700 1 _ |a Hsu, Li
|b 52
700 1 _ |a Campbell, Peter T
|b 53
700 1 _ |a Peters, Ulrike
|b 54
773 _ _ |a 10.1002/cam4.2971
|0 PERI:(DE-600)2659751-2
|n 10
|p 3563-3573
|t Cancer medicine
|v 9
|y 2020
|x 2045-7634
909 C O |o oai:inrepo02.dkfz.de:154193
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 28
|6 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 46
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 50
|6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2020
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER MED-US : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Peer review
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 0
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Präventive Onkologie
|x 1
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)C120-20160331
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21